Published online Nov 27, 2026. doi: 10.4254/wjh.123360
Revised: August 3, 2026
Accepted: October 14, 2026
Published online: November 27, 2026
Processing time: 188 Days and 10.2 Hours
Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) carries high mortality, yet current prognostic tools lack molecular precision.
To investigate the involvement of apolipoproteins (APO) in HBV-ACLF through using proteomics analyses.
We analyzed serum samples from 10 healthy controls and 20 patients with HBV-ACLF treated with a plasma exchange-centered artificial liver support system (10 survivors, 10 non-survivors) using quanititative proteomics via data-independent acquisition mass spectrometry. Differential protein expression (fold-change ≥ 1.2 or ≤ 0.833,
Among more than 200 differentially expressed proteins, he levels of APOL1, APOA1, APOC1, APOC2, and APOH were significantly lower in the HBV-ACLF groups than in the control groups, and the levels of APOC1, APOC2, and APOH were significantly lower in non-survivors than in survivor group. However, after adjusting for confounding factors, the differences were not statistically significant. Furthermore, the combined diagnosis panel of APOL1 and APOA1 showed the highest diagnostic accuracy for HBV-ACLF, with an area under the curve (AUC) of 0.940 (P = 0.0001). Similarly, the combination of APOC2 and APOH yielded the highest predictive performance for non-survival, achieving an AUC of 0.990 (P = 0.0002). The protein-protein interaction network positioned APO as hubs in lipid metabolism and inflammation pathways.
These APO may provide new clues for early detection and prognostic risk stratification of HBV-ACLF. Large sample studies are needed to validate our findings in the future.
Core Tip: Identifying potential indicators for the prognosis of acute-on-chronic liver failure in patients treated with a plasma exchange-centered artificial liver support system holds great medical significance. Thus, supplementing the relevant proteins in serum samples using the most advanced proteomics technology represents an attractive future exploration direction.